Sectors

University of Cambridge stem cell differentiation spinout Bit Bio secured $41.5m from investors including Arch Venture Partners to boost its overall funding to $50m.

The Aalto University and VTT quantum computer spinout has lined up a potential series A round with an initial $16.9m contribution from EIC Accelerator.

The Relx-backed big data analyser is reportedly lining up a confidential IPO filing in the coming weeks having previously raised $1.9bn in equity funding.

Muscle disease drug developer Avidity, which counts Eli Lilly, EMS, Takeda and ST Pharm as investors, went public in a significantly upized IPO.

Tencent-backed telemedicine service Miaoshou Doctor pulled in $84.5m that will support the strengthening of its health insurance provision.

Genomic heart disease drug developer Verve Therapeutics secured funding in a round led by GV, which also led its series A last year.

BCC, Broadway Video, WME and Chernin Group were reportedly among the investors that added $47.7m to the $93m in financing the meditation platform raised in February.

OGCI Climate Investments led a $19.3m round for the digital freight platform operator that included existing backer Total Carbon Neutrality Ventures.

The mushroom ingredient developer has now raised more than $120m in total, Greenleaf Foods co-leading a round featuring Continental Grain, Bunge, Kellogg’s, Tyson and Rich’s.

Avex, Superfly Ventures and NTT Docomo Ventures contributed to a round that will help the virtual concert broadcaster enter China and Japan.

GenScript Biotech's spinoff Legend Biotech, which counts Eli Lilly and Johnson & Johnson as backers, floated in the US.